Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

571
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
571
Air-entraining Agents01:27

Air-entraining Agents

275
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
275
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

672
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
672
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flow Cytometry Analysis of IFNγ-Induced PD-L1 Cell Surface Expression in Ovarian Cancer Cells.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Evaluating Nuclear Levels of PD-L1 in Ovarian Cancer Cells by Western Blotting.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Analysis of IFNγ-Induced Invasion of Ovarian Cancer Cells Using 3D Spheroids.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Evaluation of Metabolic Characteristics of Cancer Cells.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Analysis of PD-L1 Transcriptional Activity by Chromatin Immunoprecipitation.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Bioinformatics Analysis of Bc3, IL-8, and PD-L1 Gene Co-expression in Glioblastoma and Pan-Cancer Using Xena Platform.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Feb 6, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Metformin as an Anticancer Agent.

Ales Vancura1, Pengli Bu1, Madhura Bhagwat1

  • 1Department of Biological Sciences, St. John's University, Queens, NY 11439, USA.

Trends in Pharmacological Sciences
|August 29, 2018
PubMed
Summary
This summary is machine-generated.

Metformin, a type 2 diabetes drug, shows promise in cancer treatment by regulating key cellular pathways like AMPK and mTORC1, independent of its traditional glucose-lowering mechanisms.

Keywords:
AMPKelectron transport chainmTORC1metformin

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K

Related Experiment Videos

Last Updated: Feb 6, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K

Area of Science:

  • Pharmacology and Molecular Biology
  • Oncology
  • Endocrinology

Background:

  • Metformin is a primary treatment for type 2 diabetes (T2D), primarily acting by suppressing hepatic gluconeogenesis.
  • Beyond glucose control, metformin exhibits pleiotropic effects, including reduced cancer risk and inhibition of tumorigenesis.
  • The precise molecular mechanisms underlying metformin's actions, particularly in cancer, are still under investigation.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of metformin relevant to cancer treatment.
  • To explore how metformin regulates key cellular pathways like AMPK and mTORC1 in the context of cancer.
  • To discuss mechanisms of metformin action that may not rely on electron transport chain inhibition or ATP depletion.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies investigating metformin's effects on cellular signaling pathways.
  • Synthesis of data on metformin's impact on AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin complex 1 (mTORC1).

Main Results:

  • Metformin's regulation of AMPK and mTORC1 involves multiple mechanisms, not solely dependent on electron transport chain (ETC) inhibition.
  • These regulatory pathways are crucial for metformin's anti-cancer effects.
  • Recent findings suggest novel therapeutic applications for metformin in oncology.

Conclusions:

  • Metformin's molecular mechanisms in cancer treatment are multifaceted and extend beyond its known effects on glucose metabolism.
  • Understanding these pathways offers new avenues for utilizing metformin in cancer therapy.
  • Further research into metformin's non-glycemic effects is warranted for its application in oncology.